Karuna Could Submit Schizophrenia Drug to FDA by Mid-Year

March 20, 2023 by Dan McCue
Karuna Could Submit Schizophrenia Drug to FDA by Mid-Year
Bill Meury, president and chief executive officer, Karuna Therapeutics. (Karuna Therapeutics photo)

BOSTON — Encouraged by positive topline results from its phase 3 trial for its new therapy for adults with schizophrenia, Karuna Therapeutics announced Monday that it is on track to submit KarXT to the Food and Drug Administration for approval by summer.

If that comes to pass, the drug treatment could launch for the treatment of patients in the second half of 2024, the company said in a press release.

Karuna Therapeutics, a clinical-stage biopharmaceutical company, said KarXT met its primary endpoint during a recent phase 3 EMERGENT-3 trial demonstrating a statistically significant and clinically meaningful 8.4-point reduction in Positive and Negative Syndrome Scale total score compared to placebo (-20.6 KarXT vs. -12.2 placebo; P < .0001) at week five (Cohen’s d effect size of 0.60). 

Consistent with prior trials, KarXT also demonstrated an early and sustained statistically significant reduction of symptoms from week two (P < .05) through the end of the trial as assessed by PANSS total score.

“KarXT has now demonstrated a robust and consistent reduction of symptoms across all three registrational trials, providing a compelling picture of the potential of KarXT in schizophrenia,” said Bill Meury, the company’s president and chief executive officer, in a written statement.

“With these data, we are one step closer to a potential treatment option that could provide the first new mechanism of action to treat schizophrenia in several decades,” he added.

Schizophrenia is a serious mental illness characterized by an individual experiencing thoughts or experiences that seem out of touch with reality, disorganized speech or behavior, and decreased participation in daily activities. 

Treatment is usually lifelong and often involves a combination of medications, psychotherapy and coordinated specialty care services.

“Despite the number of currently available treatments, there remains a significant need for new treatment options for the 21 million people living worldwide with schizophrenia,” said David Walling, Ph.D., chief clinical officer at CenExel-CNS and investigator on the EMERGENT-3 trial. 

“The results from the EMERGENT-3 trial add to the growing body of data which suggest KarXT could address the symptoms of schizophrenia without the common side effects we see with current treatment options,” Walling said.

Karuna said its new drug application for KarXT in schizophrenia will incorporate the efficacy and safety data from the three placebo-controlled registrational trials, EMERGENT-1, EMERGENT-2 and EMERGENT-3, in addition to long-term safety data from the ongoing EMERGENT-4 and EMERGENT-5 trials.

Dan can be reached at [email protected] and @DanMcCue

A+
a-
  • FDA
  • Food and Drug Administration
  • Karuna Therapeutics
  • KarXT
  • Schizophrenia
  • In The News

    Health

    Voting

    Business

    Hit by Trump Trade Wars, US Economy Falls 0.2% in First Quarter, an Upgrade From Initial Estimate

    WASHINGTON (AP) — The U.S. economy shrank at a 0.2% annual pace from January through March, the first drop in... Read More

    WASHINGTON (AP) — The U.S. economy shrank at a 0.2% annual pace from January through March, the first drop in three years, as President Donald Trump’s trade wars disrupted business, the government said Thursday in a slight upgrade of its initial estimate. First-quarter growth was brought down by... Read More

    DC Mayor Seeks Business-Friendly Policies to Spark Growth Amid Loss of up to 40,000 Federal Jobs

    WASHINGTON (AP) — With the nation's capital facing a pair of overlapping budget crises, D.C. Mayor Muriel Bowser has unveiled a budget... Read More

    WASHINGTON (AP) — With the nation's capital facing a pair of overlapping budget crises, D.C. Mayor Muriel Bowser has unveiled a budget proposal that bets heavily on business-friendly policies designed to boost investment and move the city away from dependence on a dwindling number of federal jobs. “We have... Read More

    A Wave of New Owners Brings Fresh Energy to Independent Bookselling

    NEW YORK (AP) — Amber Salazar is the kind of idealist you just knew would end up running a bookstore... Read More

    NEW YORK (AP) — Amber Salazar is the kind of idealist you just knew would end up running a bookstore — a lifelong reader who felt angered “to the core” as she learned of book bans around the country. A resident of Colorado Springs, Colorado, Salazar last... Read More

    May 19, 2025
    by Dan McCue
    Blink Cutting Workforce by 20% Amid Downturn for EV Charging Market

    BOWIE, Md. — Blink Charging said Monday it is reducing its workforce by about 20% in a bid to “streamline”... Read More

    BOWIE, Md. — Blink Charging said Monday it is reducing its workforce by about 20% in a bid to “streamline” operations amid an ongoing decline in revenue. The company said the job cuts, which will be carried out into the fall, are expected to lead to... Read More

    US Cable Giants Charter and Cox, Under Assault by Streaming Services, Pursue $34.5B Merger

    Charter Communications has offered to acquire Cox Communications, a $34.5 billion merger that would combine two of the top three... Read More

    Charter Communications has offered to acquire Cox Communications, a $34.5 billion merger that would combine two of the top three cable companies in the U.S. Cox is the third largest cable television company in the country, with more than 6.5 million digital cable, internet, telephone, and... Read More

    Google Partners With Elementl Power on Nuclear Energy Sites as Power Demand for AI Grows

    WASHINGTON (AP) — Google is partnering with Elementl Power on three project sites for advanced nuclear energy as the energy... Read More

    WASHINGTON (AP) — Google is partnering with Elementl Power on three project sites for advanced nuclear energy as the energy required to power burgeoning artificial intelligence projects rises sharply. Under the agreement announced Wednesday, Google will provide capital for the projects, which the companies say will... Read More

    News From The Well
    scroll top